The importance of a defective glymphatic system in the brain accumulation of toxic amyloid-β and tau proteins has been shown in animal models (19) and suggested as an explanation for the poor efficacy of immunotherapy in patients with Alzheimer’s disease (20). This evidence concerns the gene MAPT and Alzheimer disease.